Literature DB >> 23556443

Combining genetic variations in CYP2C9 and VKORC1 with clinical factors for warfarin dosing determination improved clinical effectiveness.

Huixiao Hong1, Ansar Jawaid, Jian Wang, Jennifer Catalano, Jayne C Fox, Troy B Hawkins.   

Abstract

Entities:  

Year:  2013        PMID： 23556443     DOI： 10.2217/pgs.13.29

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Quality control metrics improve repeatability and reproducibility of single-nucleotide variants derived from whole-genome sequencing.

Authors:  W Zhang; V Soika; J Meehan; Z Su; W Ge; H W Ng; R Perkins; V Simonyan; W Tong; H Hong
Journal:  Pharmacogenomics J       Date:  2014-11-11       Impact factor: 3.550
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.